An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT03650413 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

143

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated early by the Sponsor based on the interim analysis of Study GA39925 (NCT03558152) that showed low efficacy of UTTR1147A in ulcerative colitis. Development of the drug in this indication has been terminated.

Conditions

Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: UTTR1147A

Sponsor

Genentech, Inc.